Results of a multicenter survey of diagnosis and treatment for bacterial meningitis in Japan

Journal of Infection and Chemotherapy

Volumn 16, Issue 6, 2010, Pages 396-406

  Sakata, Hiroshi ^g   Sato, Yoshitake ^a   Nonoyama, Masato ^b   Haruta, Tsunekazu ^c   Ouchi, Kazunobu ^d   Yamaguchi, Satoru ^e   Sunakawa, Keisuke ^f  

^a FUJI HEAVY INDUSTRIES LTD   (Japan)

^b Ebina General Hospital   (Japan)

^c KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^d KAWASAKI MEDICAL SCHOOL   (Japan)

^e Ito Child Clinic   (Japan)

^f KITASATO UNIVERSITY   (Japan)

^g NONE

Author keywords

Antimicrobial agent; Bacterial meningitis; Epidemiology

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; CARBAPENEM; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; DEXAMETHASONE; LINEZOLID; MEROPENEM; PANIPENEM PLUS BETAMIPRON; PENICILLIN G; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL MENINGITIS; CHILD; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS MENINGITIS; HEALTH SURVEY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMOCOCCAL MENINGITIS; PRESCHOOL CHILD; PROGNOSIS; REMISSION; SCHOOL CHILD; STREPTOCOCCUS PNEUMONIAE;

EID: 78650921586     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-010-0064-6     Document Type: Article

References (11)

1. K Ubukata N Chiba K Hasegawa R Kobayashi S Iwata K Sunakawa 2004 Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002 Antimicrob Agents Chemother 48 1488 1494 1:CAS:528:DC%2BD2cXjslClsrw%3D 15105095 10.1128/AAC.48.5.1488-1494.2004 (Pubitemid 38544349)
2. K Hasegawa N Chiba R Kobayashi SY Murayama S Iwata K Sunakawa, et al. 2004 Rapidly increasing prevalence of β-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis Antimicrob Agents Chemother 48 1509 1514 1:CAS:528:DC%2BD2cXjslClsrc%3D 15105098 10.1128/AAC.48.5.1509-1514.2004 (Pubitemid 38544352)
3. G Tudor-Williams J Frankland D Isaacs RT Mayon-White JA MacFarlane MP Slack, et al. 1989 Haemophilus influenzae type b disease in the Oxford region Arch Dis Child 64 517 519 1:STN:280:DyaL1MzitFGqug%3D%3D 2787619 10.1136/adc.64.4.517
4. A Gervaix S Suter 1991 Epidemiology of invasive Haemophilus influenzae type b infections in Geneva, Switzerland, 1976 to 1989 Pediatr Infect Dis J 10 370 374 1:STN:280:DyaK3M3ps1Cnuw%3D%3D 2067887 10.1097/00006454-199105000-00005
5. CDC 1998 Progress toward eliminating Haemophilus influenzae type b disease among infants and children United States, 1987-1997 MMWR 47 993 998
6. R Gil Prieto J San Román Montero C Gómez Alejandre LA Alvaro Meca A Rivero A Gil de Miguel 2009 Epidemiology of pneumococcal meningitis hospitalizations in pediatric population in Spain (1998-2006) Vaccine 27 2669 2673 1:STN:280:DC%2BD1MzjtlOhsg%3D%3D 19428877 10.1016/j.vaccine.2009. 02.063
7. S Black 2009 Pneumococcal vaccine reduces the rates of pneumococcal meningitis in children J Pediatr 155 149 150 19559309 10.1016/j.jpeds.2009.03. 055
8. K Hoshina Y Suzuki H Nishida K Kaneko S Matsuda M Kobayashi, et al. 2002 Trend of neonatal group B streptococcal infection during the last 15 years Pediatr Int 44 641 646 12421262 10.1046/j.1442-200X.2002.01638.x (Pubitemid 35357031)
9. Bacterial Meningitis Management Guidelines Committee. Guidelines on bacterial meningitis management. Tokyo: Igaku Shoin; 2007.
10. Gilbert DN, Moellering RC Jr, Eliopoulos GM, Chambers HF, Saag MS. The Sanford guide to antimicrobial therapy, 2009. USA: Antimicrobial Therapy Inc; 2009.
11. AR Tunkel BJ Hartman SL Kaplan BA Kaufman KL Roos WM Scheld, et al. 2004 Practice guidelines for the management of bacterial meningitis Clin Infect Dis 39 1267 1284 15494903 10.1086/425368 (Pubitemid 39458512)